The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma

Multiple myeloma (MM) is a malignant disorder of plasma cells primarily affecting elderly patients with a median age at diagnosis in the late 60s to early 70s [1]. It is the second most commonly diagnosed hematological neoplasm with an estimated incidence of 30,280 cases in 2017 and prevalence of 118,539 in 2014 [2]. With effective new agents now available including proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies, significant advances have been made in the treatment of MM.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research